Nunzia Pharmaceutical Pink Sheet Forecast - Simple Regression
| NUNZ Stock | USD 0.0001 0.00 0.00% |
Nunzia Pink Sheet outlook is based on your current time horizon.
At this time the relative strength index (rsi) of Nunzia Pharmaceutical's share price is below 20 . This indicates that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Nunzia Pharmaceutical hype-based prediction, you can estimate the value of Nunzia Pharmaceutical from the perspective of Nunzia Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of Nunzia Pharmaceutical on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0 and the sum of the absolute errors of 0. Nunzia Pharmaceutical after-hype prediction price | USD 1.0E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Nunzia |
Nunzia Pharmaceutical Additional Predictive Modules
Most predictive techniques to examine Nunzia price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Nunzia using various technical indicators. When you analyze Nunzia charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Nunzia Pharmaceutical Simple Regression Price Forecast For the 28th of January
Given 90 days horizon, the Simple Regression forecasted value of Nunzia Pharmaceutical on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0, mean absolute percentage error of 0, and the sum of the absolute errors of 0.Please note that although there have been many attempts to predict Nunzia Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Nunzia Pharmaceutical's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Nunzia Pharmaceutical Pink Sheet Forecast Pattern
| Backtest Nunzia Pharmaceutical | Nunzia Pharmaceutical Price Prediction | Buy or Sell Advice |
Nunzia Pharmaceutical Forecasted Value
In the context of forecasting Nunzia Pharmaceutical's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Nunzia Pharmaceutical's downside and upside margins for the forecasting period are 0.0001 and 0.0001, respectively. We have considered Nunzia Pharmaceutical's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Nunzia Pharmaceutical pink sheet data series using in forecasting. Note that when a statistical model is used to represent Nunzia Pharmaceutical pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 30.3989 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.0 |
| SAE | Sum of the absolute errors | 0.0 |
Predictive Modules for Nunzia Pharmaceutical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Nunzia Pharmaceutical. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Nunzia Pharmaceutical After-Hype Price Density Analysis
As far as predicting the price of Nunzia Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Nunzia Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Nunzia Pharmaceutical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Nunzia Pharmaceutical Estimiated After-Hype Price Volatility
In the context of predicting Nunzia Pharmaceutical's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Nunzia Pharmaceutical's historical news coverage. Nunzia Pharmaceutical's after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered Nunzia Pharmaceutical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Nunzia Pharmaceutical is very steady at this time. Analysis and calculation of next after-hype price of Nunzia Pharmaceutical is based on 3 months time horizon.
Nunzia Pharmaceutical Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Nunzia Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nunzia Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Nunzia Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.0001 | 0.0001 | 0.00 |
|
Nunzia Pharmaceutical Hype Timeline
Nunzia Pharmaceutical is now traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Nunzia is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on Nunzia Pharmaceutical is about 0.0%, with the expected price after the next announcement by competition of 0.00. About 82.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.28. Nunzia Pharmaceutical last dividend was issued on the 4th of December 2019. The entity had 1:7000 split on the 4th of December 2019. Given the investment horizon of 90 days the next estimated press release will be uncertain. Check out Historical Fundamental Analysis of Nunzia Pharmaceutical to cross-verify your projections.Nunzia Pharmaceutical Related Hype Analysis
Having access to credible news sources related to Nunzia Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict Nunzia Pharmaceutical's future price movements. Getting to know how Nunzia Pharmaceutical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Nunzia Pharmaceutical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| QEBR | Virtual Medical International | 0.00 | 0 per month | 0.00 | 0.15 | 100.00 | 0.00 | 375.00 | |
| OWCP | OWC Pharmaceutical Research | 0.00 | 2 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ATTBF | Abattis Bioceuticals Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ARYX | Aryx Therapeutics I | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ISOLF | Isodiol International | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| INSD | Instadose Pharma Corp | 0.00 | 0 per month | 0.00 | (0.13) | 0.00 | 0.00 | 90.91 | |
| WIBFF | West Island Brands | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ONSS | Onassis Holdings Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NNRX | Nutranomics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| VFRM | Veritas Farms | 0.00 | 0 per month | 0.00 | 0.1 | 100.00 | (50.00) | 150.00 |
Other Forecasting Options for Nunzia Pharmaceutical
For every potential investor in Nunzia, whether a beginner or expert, Nunzia Pharmaceutical's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Nunzia Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Nunzia. Basic forecasting techniques help filter out the noise by identifying Nunzia Pharmaceutical's price trends.Nunzia Pharmaceutical Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nunzia Pharmaceutical pink sheet to make a market-neutral strategy. Peer analysis of Nunzia Pharmaceutical could also be used in its relative valuation, which is a method of valuing Nunzia Pharmaceutical by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Nunzia Pharmaceutical Market Strength Events
Market strength indicators help investors to evaluate how Nunzia Pharmaceutical pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nunzia Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Nunzia Pharmaceutical pink sheet market strength indicators, traders can identify Nunzia Pharmaceutical entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
Story Coverage note for Nunzia Pharmaceutical
The number of cover stories for Nunzia Pharmaceutical depends on current market conditions and Nunzia Pharmaceutical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Nunzia Pharmaceutical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Nunzia Pharmaceutical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Nunzia Pharmaceutical Short Properties
Nunzia Pharmaceutical's future price predictability will typically decrease when Nunzia Pharmaceutical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Nunzia Pharmaceutical often depends not only on the future outlook of the potential Nunzia Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Nunzia Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 284.9 M | |
| Cash And Short Term Investments | 131.00 |
Additional Tools for Nunzia Pink Sheet Analysis
When running Nunzia Pharmaceutical's price analysis, check to measure Nunzia Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nunzia Pharmaceutical is operating at the current time. Most of Nunzia Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Nunzia Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nunzia Pharmaceutical's price. Additionally, you may evaluate how the addition of Nunzia Pharmaceutical to your portfolios can decrease your overall portfolio volatility.